121
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Mir-5100 Mediates Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells Via Targeting SCAI

, , &

References

  • Siegel R, Ma J, Zou Z, et al. Cancer statistics. CA Cancer J Clin. 2014;64(1):9–29. (2014). doi:10.3322/caac.21208.
  • Gao L, Zhao C, Li S, et al. circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma. Mol Carcinog. 2019;58(10):1783–1794. doi:10.1002/mc.23065.
  • Global Burden Of Disease Cancer C, Fitzmaurice C, Abate D, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 2019. doi:10.1001/jamaoncol.2019.2996.
  • Jiang S, Dong Y. Human papillomavirus and oral squamous cell carcinoma: A review of HPV-positive oral squamous cell carcinoma and possible strategies for future. Curr Probl Cancer. 2017;41(5):323–327. doi:10.1016/j.currproblcancer.2017.02.006.
  • Dumache R, Rogobete AF, Andreescu N, et al. Genetic and epigenetic biomarkers of molecular alterations in oral carcinogenesis. Clin Lab. . 2015;61(10):1373–1381. doi:10.7754/clin.lab.2015.150327.
  • Min A, Zhu C, Peng S, et al. MicroRNAs as important players and biomarkers in oral carcinogenesis. Biomed Res Int. 2015;2015:1. doi:10.1155/2015/186904.
  • Karimi L, Zeinali T, Hosseinahli N, et al. miRNA-143 replacement therapy harnesses the proliferation and migration of colorectal cancer cells in vitro. J Cell Physiol. 2019;234(11):21359–21368. doi:10.1002/jcp.28745.
  • Liao C-H, Liu Y, Wu Y-F, et al. microRNA-329 suppresses epithelial-to-mesenchymal transition and lymph node metastasis in bile duct cancer by inhibiting laminin subunit beta 3. J Cell Physiol. 2019;234(10):17786–17799. doi:10.1002/jcp.28404.
  • Javandoost E, Majd EF, Rostamian H, et al. Role of microRNAs in chronic lymphocytic leukemia pathogenesis. Curr Med Chem. 2019. doi:10.2174/0929867326666190911114842.
  • Sadri Nahand J, Moghoofei M, Salmaninejad A, et al. Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review. Int J Cancer. . 2020;146(2):305–320. doi:10.1002/ijc.32688.
  • Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. . 2015;15(6):321–333. doi:10.1038/nrc3932.
  • Weng JH, Yu CC, Lee YC, Lin CW, Chang WW, Kuo YL. miR-494-3p induces cellular senescence and enhances radiosensitivity in human oral squamous carcinoma cells. Int J Mol Sci. 2016;17:1092. doi:10.3390/ijms17071092.
  • Vafadar A, Shabaninejad Z, Movahedpour A, et al. Long Non-Coding RNAs As Epigenetic Regulators in Cancer. CPD. 2019;25(33):3563–3577. doi:10.2174/1381612825666190830161528.
  • Huang C, Song H, Lai L. The role and mechanism of microRNA‐18a‐5p in oral squamous cell carcinoma. Mol Med Rep. . 2019;20(2):1637–1644. doi:10.3892/mmr.2019.10403.
  • Mirzaei H, Fathullahzadeh S, Khanmohammadi R, et al. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia. J Cell Physiol. . 2018;233(2):888–900. doi:10.1002/jcp.25799.
  • Mohammadi M, Goodarzi M, Jaafari MR, et al. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma. Cancer Gene Ther. . 2016;23(11):371–372. doi:10.1038/cgt.2016.45.
  • Mirzaei H, Gholamin S, Shahidsales S, et al. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. Eur J Cancer. 2016;53:25–32. doi:10.1016/j.ejca.2015.10.009.
  • Shi J, Bao X, Liu Z, et al. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma. Theranostics. 2019;9(4):920–931. doi:10.7150/thno.30339.
  • Lin L, Liu D, Liang H, et al. MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein. Int J Clin Exp Pathol. 2015;8(6):6646–6655.
  • Zheng H, Ma R, Wang Q, et al. MiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells. Oncotarget. 2015;6(29):27805–27815. doi:10.18632/oncotarget.4738.
  • Xu D, Gu M, Liu HL. MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression. Eur Rev Med Pharmacol Sci. 2019;23(2):641–648. doi:10.26355/eurrev_201901_16878.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.1262.
  • Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med. . 2009;60(1):167–179. doi:10.1146/annurev.med.59.053006.104707.
  • Gorenchtein M, Poh CF, Saini R, et al. MicroRNAs in an oral cancer context - from basic biology to clinical utility. J Dent Res. . 2012;91(5):440–446. doi:10.1177/0022034511431261.
  • Li L, Ma HQ. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B. Mol Med Rep. 2015;12(2):3156–3162. doi:10.3892/mmr.2015.3761.
  • Ding N, Luo M, Liao X-L, et al. MicroRNA-378 promotes the malignant progression of oral squamous cell carcinoma by mediating FOXN3. Eur Rev Med Pharmacol Sci. 2019;23(14):6202–6210. doi:10.26355/eurrev_201907_18437.
  • Xu Y-X, Sun J, Xiao W-L, et al. MiR-4513 mediates the proliferation and apoptosis of oral squamous cell carcinoma cells via targeting CXCL17. Eur Rev Med Pharmacol Sci. 2019;23(9):3821–3828. doi:10.26355/eurrev_201905_17809.
  • Huang H, Jiang Y, Wang Y, et al. miR-5100 promotes tumor growth in lung cancer by targeting Rab6. Cancer Lett. 2015;362(1):15–24. doi:10.1016/j.canlet.2015.03.004.
  • Jacob H, Stanisavljevic L, Storli KE, et al. A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer. Sci Rep. . 2018;8(1):9. doi:10.1038/s41598-018-24519-4.
  • Pu Y, Wang LIN, Wu H, et al. High MMP-21 expression in metastatic lymph nodes predicts unfavorable overall survival for oral squamous cell carcinoma patients with lymphatic metastasis. Oncol Rep. 2014;31(6):2644–2650. doi:10.3892/or.2014.3124.
  • Wang Q, Lv LK, Li Y, et al. MicroRNA-655 suppresses cell proliferation and invasion in oral squamous cell carcinoma by directly targeting metadherin and regulating the PTEN/AKT pathway. Mol Med Rep. 2018;18:3106–3114. doi:10.3892/mmr.2018.9292.
  • Wu J, Chen Z, Zhang L et al. Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial-mesenchymal transition pathway. J Cell Biochem. 2020;121(1):867–875. doi:10.1002/jcb.29331.
  • Liu XB, Wang J, Li K, et al. Sp1 promotes cell migration and invasion in oral squamous cell carcinoma by upregulating Annexin A2 transcription. Mol Cell Probes. 2019;46:7. doi:10.1016/j.mcp.2019.06.007.
  • Zhang XN, Sai B, Wang F, et al. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Mol Cancer. 2019;18:15. doi:10.1186/s12943-019-0959-5.
  • Wang XM, Lu XB, Geng ZS, et al. LncRNA PTCSC3/miR-574-5p governs cell proliferation and migration of papillary thyroid carcinoma via Wnt/-catenin signaling. J Cell Biochem. 2017;118(12):4745–4752. doi:10.1002/jcb.26142.
  • Liu X, Shang W, Zheng F. Long non-coding RNA NEAT1 promotes migration and invasion of oral squamous cell carcinoma cells by sponging microRNA-365. Exp Ther Med. 2018;16:2243–2250. doi:10.3892/etm.2018.6493.
  • Lai Y-H, Liu H, Chiang W-F, et al. MiR-31-5p-ACOX1 axis enhances tumorigenic fitness in oral squamous cell carcinoma via the promigratory prostaglandin E2. Theranostics. 2018;8(2):486–504. doi:10.7150/thno.22059.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.